Our findings showed that the KOR system could act directly on tumor angiogenesis to suppress VEGFR2 expression; to our knowledge, this is the first report of an endogenous angiogenesis inhibitor of a ligand-receptor system that suppresses the expression of VEGF receptor. Here, OPRK1 is linked to neoplasm.